4
weillcornellbrainandspine.org Brain & Spine Center News and Updates From Weill Cornell Medicine Neurological Surgery Spring 2019 A MESSAGE FROM THE CHAIR Philip E. Stieg, PhD, MD Dear Friends and Colleagues, Spring is a time for renewal for everyone, and it’s an especially refreshing time in medicine. Every March we get to meet our new residents, the soon-to-be medical school graduates who are about to embark on their journey of neurosurgical training. Nothing gives me more satisfaction each year than welcoming our new residents (except perhaps the pride I feel as I send our residency graduates out into their new professional lives), and I Iook forward to spending the next seven years helping them become the next generation of leaders in neurosurgery. See page 4 of this newsletter to meet our incoming residents, Alexandra Giantini Larsen and Andrew Garton. This year spring also brought with it the commercial availability of DBS for epilepsy (see news at right), several prestigious awards given to our faculty and fellows (page 3), and an expanded presence in Brooklyn (page 4). We are looking forward to a full roster of spring CME courses and to welcoming our special Grand Rounds speaker, Dr. David Acosta, to kick off Diversity Week later this month (page 2). I am also proud to announce the launch of my new podcast, This Is Your Brain With Dr. Phil Stieg. The podcast is a way for me to bring the fascinating conversations I have with colleagues and patients to a wide audience. I look forward to continuing these conversations, and I invite your feedback. See page 3 for more information about the podcast. Finally, with warm weather comes the return to sports for many young (and not-so-young) athletes, and along with that the risk of head injuries. Our multidisciplinary Concussion and Brain Injury Clinic is an excellent resource for worried patients and their parents and provides expert advice and treatment options (see page 3 for leadership news from the Concussion Clinic, and visit concussion.weillcornell.org for more information). Happy Spring! Yours in good health, Phil Stieg A fter more than a decade of testing, an advanced procedure for epilepsy is now available to patients whose seizures have not been successfully managed with medication. Deep brain stimulation (DBS), which has been effective for Parkinson’s disease and other movement disorders, was approved in 2018 by the Food and Drug Administration for medication-resistant epilepsy after a seven-year-long clinical trial. It is now commercially available in the United States in select locations, including the Weill Cornell Medicine Brain and Spine Center. Dr. Michael Kaplitt, whose work throughout the clinical trial helped win FDA approval, was the first surgeon in New York to perform deep brain stimulation for epilepsy. The multi-center clinical trial, called Stimula- tion of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE), tested the new device in more than 100 people over seven years; the median reduction in seizures was 75 percent. Study results were published in the journal Epilepsia (“Electrical stimulation of the anterior nucleus of thala- mus for treatment of refractory epilepsy”) in 2010, reporting successful results from the first two years; a 2015 paper published in Neurology at five years concluded that “long-term follow-up of ANT [anterior nucleus of the thalamus] deep brain stimulation showed sustained efficacy and safety in a treatment-resistant population,” and in 2018 the FDA approved the device for use in the United States. In early 2019 the device became commercially available, and the first insurance companies began provid- ing coverage for the procedure. “It’s extremely gratifying to see this procedure become available to patients,” says Dr. Kaplitt. “I was part of the study group for so many years, and I had become convinced that this was an effective way to help patients control seizures.” Dr. Kaplitt was the first in the world to test gene therapy for Parkinson’s disease and in 2017 became the first neuro- surgeon in New York to use focused ultrasound to treat essential tremor. “I was honored to participate in the FDA meeting that led to the ap- proval of the device for epilepsy,” he says, “and I am pleased that this FDA approval now allows us to provide a minimally invasive intervention to lessen seizures and vastly improve quality of life in patients with epilepsy.” The technology, made by Medtronic, consists of the same DBS device cur- rently used for movement disorders plus an external patient programmer that patients can use to control the stimulation. The device is implanted in the chest below the collar bone and delivers electrical stimulation over tiny wires to the ANT, interrupting the propagation of seizures. (The elec- trodes can be directed to very specific points in the brain; different parts of the brain can be stimulated to relieve the symptoms of Parkinson’s disease, essential tremor, and now epilepsy.) Deep brain stimulation now joins other minimally invasive neurosurgical options for patients with epilepsy that does not respond to medication. Weill Cornell Medicine is one of the few places in the United States to of- fer a wide range of options for patients with epilepsy, including tradition- al neurosurgery, laser surgery, and neurostimulation therapy—which in- cludes vagal nerve stimulation (VNS), responsive neurostimulation (RNS), and now deep brain stimulation (DBS). For more information about DBS for epilepsy, please contact Dr. Kaplitt’s office (212-746-4966). Deep Brain Stimulation for Epilepsy

Brain&Spine Center...Directed by Dr. Rohan Ramakrishna A comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Brain&Spine Center...Directed by Dr. Rohan Ramakrishna A comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding

weillcornellbrainandspine.org

Brain&Spine CenterNews and Updates From Weill Cornell Medicine Neurological Surgery Spring 2019

A MESSAGE FROM THE CHAIR

Philip E. Stieg, PhD, MD

Dear Friends and Colleagues,

Spring is a time for renewal for everyone, and it’s an especially refreshing time in medicine. Every March we get to meet our new residents, the soon-to-be medical school graduates who are about to embark on their journey of neurosurgical training. Nothing gives me more satisfaction each year than welcoming our new residents (except perhaps the pride I feel as I send our residency graduates out into their new professional lives), and I Iook forward to spending the next seven years helping them become the next generation of leaders in neurosurgery. See page 4 of this newsletter to meet our incoming residents, Alexandra Giantini Larsen and Andrew Garton.

This year spring also brought with it the commercial availability of DBS for epilepsy (see news at right), several prestigious awards given to our faculty and fellows (page 3), and an expanded presence in Brooklyn (page 4). We are looking forward to a full roster of spring CME courses and to welcoming our special Grand Rounds speaker, Dr. David Acosta, to kick off Diversity Week later this month (page 2).

I am also proud to announce the launch of my new podcast, This Is Your Brain With Dr. Phil Stieg. The podcast is a way for me to bring the fascinating conversations I have with colleagues and patients to a wide audience. I look forward to continuing these conversations, and I invite your feedback. See page 3 for more information about the podcast.

Finally, with warm weather comes the return to sports for many young (and not-so-young) athletes, and along with that the risk of head injuries. Our multidisciplinary Concussion and Brain Injury Clinic is an excellent resource for worried patients and their parents and provides expert advice and treatment options (see page 3 for leadership news from the Concussion Clinic, and visit concussion.weillcornell.org for more information).

Happy Spring!

Yours in good health,

Phil Stieg

After more than a decade of testing, an advanced procedure for epilepsy is now available to patients whose seizures have not been

successfully managed with medication. Deep brain stimulation (DBS), which has been effective for Parkinson’s disease and other movement disorders, was approved in 2018 by the Food and Drug Administration for medication-resistant epilepsy after a seven-year-long clinical trial. It is now commercially available in the United States in select locations, including the Weill Cornell Medicine Brain and Spine Center.

Dr. Michael Kaplitt, whose work throughout the clinical trial helped win FDA approval, was the first surgeon in New York to perform deep brain stimulation for epilepsy. The multi-center clinical trial, called Stimula-tion of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE), tested the new device in more than 100 people over seven years; the median reduction in seizures was 75 percent. Study results were published in the journal Epilepsia (“Electrical stimulation of the anterior nucleus of thala-mus for treatment of refractory epilepsy”) in 2010, reporting successful results from the first two years; a 2015 paper published in Neurology at five years concluded that “long-term follow-up of ANT [anterior nucleus of the thalamus] deep brain stimulation showed sustained efficacy and safety in a treatment-resistant population,” and in 2018 the FDA approved the device for use in the United States. In early 2019 the device became commercially available, and the first insurance companies began provid-ing coverage for the procedure.

“It’s extremely gratifying to see this procedure become available to patients,” says Dr. Kaplitt. “I was part of the study group for so many years, and I had become convinced that this was an effective way to help patients control seizures.” Dr. Kaplitt was the first in the world to test gene therapy for Parkinson’s disease and in 2017 became the first neuro-surgeon in New York to use focused ultrasound to treat essential tremor.

“I was honored to participate in the FDA meeting that led to the ap-proval of the device for epilepsy,” he says, “and I am pleased that this FDA approval now allows us to provide a minimally invasive intervention to lessen seizures and vastly improve quality of life in patients with epilepsy.”

The technology, made by Medtronic, consists of the same DBS device cur-rently used for movement disorders plus an external patient programmer that patients can use to control the stimulation. The device is implanted in the chest below the collar bone and delivers electrical stimulation over tiny wires to the ANT, interrupting the propagation of seizures. (The elec-trodes can be directed to very specific points in the brain; different parts of the brain can be stimulated to relieve the symptoms of Parkinson’s disease, essential tremor, and now epilepsy.)

Deep brain stimulation now joins other minimally invasive neurosurgical options for patients with epilepsy that does not respond to medication. Weill Cornell Medicine is one of the few places in the United States to of-fer a wide range of options for patients with epilepsy, including tradition-al neurosurgery, laser surgery, and neurostimulation therapy—which in-cludes vagal nerve stimulation (VNS), responsive neurostimulation (RNS), and now deep brain stimulation (DBS). For more information about DBS for epilepsy, please contact Dr. Kaplitt’s office (212-746-4966).

Deep Brain Stimulation for Epilepsy

Page 2: Brain&Spine Center...Directed by Dr. Rohan Ramakrishna A comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding

Global Neurosurgery

We were so proud to host “Global Neurosurgery 2019: A Practical Symposium” in January. This sold-out meeting connected neuro-surgeons, other physicians, and health policy leaders to identify

population-based needs in different regions and assess current successes and continued barriers. The assembled leaders in global neurosurgery used these experiences and perspectives to begin formulating a strategy for improving global health and developing metrics to assess success.

Upcoming CoursesApril 18, 2019Spine Tumor Seminar Directed by Dr. Ali Baaj and Dr. Susan PannulloState-of-the-art treatment paradigms for patients with primary or metastatic spinal tumors, including surgical and non-surgical options

May 9, 2019 NEW FOR 2019! Brain Metastases SymposiumDirected by Dr. Rohan RamakrishnaA comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding problems in the era of immunotherapy and stereotactic radiation

May 31, 2019Neurotrauma Update 2019: Minimizing Chronic Effects of Acute Neurological TraumaDirected by Kai-Ming Fu, MD, PhD, and Amanda Fazio, MSN, FNP-BC A framework for updating practitioners in the current standard of care for patients with traumatic neurological injuries. This year’s focus is on the long-term effects of traumatic injuries.

June 7–8, 2019 EXPANDED FOR 2019!Minimally Invasive Cranial Neurosurgery: Recent Technical Advances with Hands‐On SymposiumDirected by Dr. Theodore Schwartz and Dr. Mark SouweidaneLectures and cadaver training on endoscopic endonasal techniques and a wide variety of other advanced intracranial approaches

For more information about courses, visit weillcornellbrainandspine.org/continuing-medical-education

Surgery of the Thoracic Spine: Principles and TechniquesDr. Ali A. Baaj and co-editors Kumar Kakarla, MD (Barrow), and Han Jo Kim, MD (HSS) pub-lished this comprehensive text, which includes an overview of the thoracic region and its unique role in pulmonary function, along with in-depth reviews of advanced surgical practic-es, including neuromonitoring and intraopera-tive navigation. Surgical options for different types of scoliosis are covered in depth.

2 weillcornellbrainandspine.org

Now in Bookstores

Clockwise from above left: Walter Jean, MD, delivered his presentation about neurosurgery in Vietnam via live stream from Hanoi; Drs. Caitlin Hoffman and Roger Härtl co-directed the meeting; some of the distinguished faculty members who came from around the globe to be a part of this meeting.

COMING THIS FALLThe following courses have not yet been approved for CME credit; please visit weillcornellbrainandspine.org for updates.

SeptemberNeurosurgery and Beyond: Addressing the Neurocognitive, Behavioral, and Emotional Needs of Our PatientsAn interdisciplinary exploration of the complex interplay between the physical, emotional, and cognitive aspects of neurosurgical conditions

October3rd Annual Weill Cornell Medicine Pituitary SymposiumA comprehensive overview and discussion of the evaluation; manage-ment; and medical, surgical, and radiation treatments of pituitary disorders

NovemberEndoscopic and Open Surgical Approaches for Craniosynostosis: A Hands-On Practical CourseA combination of classroom instruction and hands-on practice using state-of-the-art 3D-printed models created from scans of actual patients

December NYC-MISS 20192019 13th Annual New York City Minimally Invasive Spine, Robotics and 3D Navigation Symposium: Case-Based and Hands-OnNeurosurgeons and orthopedic spine surgeons from around the world as-semble here each December to learn, network, and debate latest technolo-gies for minimal-access spine surgery.

Diversity Week Grand Rounds

David A. Acosta, MDChief Diversity and Inclusion OfficerAmerican Association of Medical Colleges

Monday, April 22, 7:30 am

Belfer Research Building, 302 C/D Residents and students are invited to coffee with Dr. Acosta in the Starr 651 conference room immediately following Grand Rounds.Please RSVP to: [email protected]

Our weekly Grand Rounds series features speakers from a wide range of institutions and disciplines. See the full calendar at weillcornellbrainandspine.org/grand-rounds

Page 3: Brain&Spine Center...Directed by Dr. Rohan Ramakrishna A comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding

Young Investigator AwardDr. Rupa Gopalan Juthani was named winner of the 2019 American Brain Tumor Association’s Young Investigator Award. The award will be presented at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in San Diego, California, to be held from April 13–17.

Dr. Juthani’s abstract, “Targeted Ultra-Small Nanoparticles as a Multi-Modal Platform for Enhanced Drug Delivery to Primary and Metastatic Brain Tu-mors,” earned her this distinction. Her abstract tackles the difficulties of treat-ing malignant brain tumors due to the blood brain barrier. It investigates the use of ultra-small silica nanoparticles containing Cy5 fluorescent dye (C’dots) as a vehicle for enhanced drug delivery through the central nervous system. Her team’s findings conclusively showed that C’dots presented a viable and attractive platform for delivering drugs through the central nervous system.

Charlie Kuntz Scholar AwardDr. Sertac Kirnaz, a fellow on Dr. Roger Härtl’s spine team, has been awarded a 2019 Charlie Kuntz Scholar Award for his abstract, “Retrospective Review of Immediate Restoration of Lordosis in Single-level Minimally Invasive Transforaminal Lumbar Interbody Fu-sion (MI-TLIF): A combination of Static and Expandable Interbody Cages.” The Kuntz Award, given by the Joint Section on Disorders of the Spine and Peripher-al Nerves (DSPN) of the Congress of Neurological Surgeons (CNS), is awarded every year to neurosurgical residents or fellows who author outstanding abstracts detailing a laboratory or clinical investigation into spinal disorders. Children’s Brain Tumor Project Secures $1 Million GrantDr. Jeffrey Greenfield, co-founder of the Weill Cornell Medicine Children’s Brain Tumor Project, was recently awarded a $1.08 mil-lion grant from the Patrick Bayly Marsano Foundation. The gift will fund a two-year initiative to expand the lab’s cellular and molecular precision medicine approach to pediatric brain tumor therapy, with a goal of establishing safe, curative patient-specific therapies for devastating pediatric brain tumors, including gliomatosis cerebri, which claimed young Patrick’s life.

Clinicians, computational biologists, neu-roscientists, immunologists, biochemists, and stem cell biologists will work together to conduct next-generation sequencing on every pediatric brain tumor resected at Weill Cornell Medicine—an anticipated 50 to 80 children. They will identify new mutations specific to the cell population and to the patient, and create cell repositories and mouse models to test different targeted therapeutics. Following a comprehensive review of the genetics, cell biology and pharmaco genomics of patient-specific tumors, a customized therapeu-tic regimen will be determined for each patient.

Brain tumors are the most common tumors found in children, and the most fatal. The Children’s Brain Tumor Project aims to improve the outcome for children with brain tumors by advancing translational and clinical research that focuses on targeted therapy, effective drug delivery, and low treatment-related toxicity.

For more information, visit childrensbraintumorproject.org

Awards, Grants, and Honors

weillcornellbrainandspine.org 3

This Is Your Brain Podcast

Dr. Philip Stieg has launched a new podcast called This Is Your Brain With Dr. Phil Stieg. Weekly episodes will delve into the mysteries and new discoveries about how the brain works, what can go wrong with it, and the most effective ways to keep it healthy.

On the show, Dr. Stieg talks with leading medical experts in brain science as well as patients who share their stories of recovery. These conversations reveal both the medical science and the personal challenges of a wide variety of brain issues, including the emotional and physical impact of being diagnosed with a brain disorder. They provide a view into how patients forge ahead through the grueling path to healing—often coming to grips with a new sense of self—and how doctors and surgeons can help guide them along the path to recovery.

The initial episodes are a two-part conversation with Alissa Rubin, the New York Times journalist who suffered devastating injuries in a helicopter crash in 2013 while on assignment in Afghanistan. Ms. Rubin and Dr. Stieg discuss not only the accident and her physical recovery, but also the emotional and cogni-tive implications of traumatic brain injuries. Future episodes will cover many aspects of the brain, including concussion, sleep apnea, anxiety, nutrition, ad-diction, and sex. In one upcoming episode Dr. Stieg will even cover miraculous awakenings from coma—and how to define what “awake” really means.

This Is Your Brain With Dr. Phil Stieg brings a down-to-earth approach to these conversations about the complicated human brain in all its wonder, and prom-ises to help listeners make the best decisions about their brain health.

This Is Your Brain With Dr. Phil Stieg is now available in the iTunes store, Google Play, and Spotify, as well as on drphilstieg.com.

Concussion LeadershipDr. Nitin Sethi was named Director of the Weill Cornell Medicine Concussion and Brain Injury Clinic, where he will head up an outstanding multidisciplinary team that takes a neurological approach to a neurological injury. (Although that sounds self-evident, not every concussion treatment center does.) The team consists of specially trained neuropsychologists, neurotrauma specialists, and neurologists—both adult and pediatric. Dr. Sethi is a board-certified neurologist who is a concussion consultant with the NFL and is the Chief Medical Officer of the New York State Athletic Commission, which oversees combative sports and professional wrestling. The other leaders of the concussion team include neuropsychologists Kenneth Perrine and Amanda Sacks-Zimmerman and child neurology specialist Barry Kosofsky. Visit concussion.weillcornell.org for more information.

Left to right: Kenneth Perrine, PhD, ABPP-CN, Amanda Sacks-Zimmerman, PhD, ABPP-CN, Nitin Sethi, MD, and Barry Kosofsky, MD

Patrick Bayly Marsano was just 10 years old when he succumbed to the deadly brain tumor gliomatosis cerebri.

Dr. Roger Härtl and his research fellow Dr. Sertac Kirnaz

Page 4: Brain&Spine Center...Directed by Dr. Rohan Ramakrishna A comprehensive overview of metastatic CNS disease for the physician and support staff, including novel approaches to longstanding

Follow the Weill Cornell Brain and Spine Center on Facebook

4 weillcornellbrainandspine.org Copyright 2019 Weill Cornell Medical College. All Rights Reserved.

NewYork-PresbYteriaN weill CorNell MediCiNeCerebrovascular Surgery

Aneurysms, AVMs, carotid occlusive diseaseDr. Philip E. Stieg 212-746-4684

Dr. Jared Knopman 212-746-5149

Brain Tumor SurgeryBenign and malignant tumors in adults and children

Dr. Philip E. Stieg 212-746-4684Dr. Rohan Ramakrishna 212-746-1996Dr. Theodore Schwartz 212-746-5620

Dr. Babacar Cisse 646-962-3389Dr. Mark Souweidane 212-746-2363 (pediatric)Dr. Jeffrey Greenfield 212-746-2363 (pediatric)Dr. Caitlin Hoffman 212-746-2363 (pediatric)

Epilepsy SurgeryCurative and palliative surgical approaches to epilepsy

Dr. Theodore H. Schwartz 212-746-5620Dr. Michael Kaplitt 212-746-4966

Dr. Caitlin Hoffman 212-746-2363 (pediatric)

Interventional NeuroradiologyMinimally invasive image-guided diagnosis and treatment

Dr. Y. Pierre Gobin 212-746-4998Dr. Athos Patsalides 212-746-2821Dr. Jared Knopman 212-746-5149

Stereotactic and Functional NeurosurgeryParkinson’s disease, essential tremor, and pain

Dr. Michael Kaplitt 212-746-4966

Neuro-oncologyComprehensive treatment options for cancers of the brain and spine

Dr. Howard Fine 212-746-2596Dr. Susan Pannullo 212-746-2438

Dr. Rajiv Magge 646-962-2185Dr. Babacar Cisse 646-962-3389

Dr. Rohan Ramakrishna 212-746-1996

NeuropsychologyTesting, imaging, psychotherapy, and cognitive remediation

Kenneth Perrine, PhD 212-746-2197Amanda Sacks-Zimmerman, PhD 212-746-3356

Jessica Spat-Lemus, PhD 646-962-3336 (pediatric)

Pediatric NeurosurgeryTreatment of the full spectrum of CNS conditions in children

Dr. Mark Souweidane 212-746-2363Dr. Jeffrey Greenfield 212-746-2363Dr. Caitlin Hoffman 212-746-2363

Pituitary Tumors/NeuroendocrinologyEndoscopic approaches to anterior skull base surgery

Dr. Theodore H. Schwartz 212-746-5620Dr. Rohan Ramakrishna 212-746-1996

Dr. Babacar Cisse 646-962-3389Dr. Jeffrey Greenfield 212-746-2363 (pediatric)

Dr. Georgiana Dobri 646-962-3556 (neuroendocrinology)

Spinal SurgeryComprehensive care for spine conditions and injuries

Dr. Roger Härtl 212-746-2152Dr. Eric Elowitz 212-746-2870Dr. Kai-Ming Fu 212-746-2260

Dr. Ali Baaj 212-746-1164Dr. Michael Virk 646-962-3388

Stereotactic RadiosurgeryNoninvasive treatments for brain tumors and other conditions

Dr. Susan Pannullo 212-746-2438Dr. Rohan Ramakrishna 212-746-1996

NewYork-PresbYteriaN lower MaNhattaNDr. Samuel Kim 646-962-5115

NewYork-PresbYteriaN QueeNsDr. Jaime Nieto 718-670-1837

Dr. Ning Lin 718-670-1837Dr. Srikanth Boddu 718-303-3739

Dr. Rupa Gopalan Juthani 718-670-1837

NewYork-PresbYteriaN brooklYN MethodistDr. Martin Zonenshayn 718-246-8660

Dr. Michael Ayad 718-780-3070 Dr. George Selas 718-780-3000

Welcome to New Faculty at NYP Brooklyn Methodist

We are proud to welcome three outstanding neurosurgeons to our faculty as we continue our integration with NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Martin Zonenshayn Dr. Zonenshayn, chief of the neurosurgery divi-sion at NewYork-Presbyterian Brooklyn Methodist Hospital, is a board-certified neurosurgeon with expertise in a wide range of disorders of the central nervous system. Dr. Zonenshayn specializes in brain and spine tumors, stereotactic and functional surgery, and degenerative spine conditions. He has been included in lists of Top Doctors in the New York Metro Area as well as in New York magazine’s list of Top Doctors in New York.

Dr. Michael AyadDr. Ayad is Director of Cerebrovascular and Endo -vascular Neurosurgery at NYP Brooklyn Methodist. He is board-certified in neurosurgery and holds two U.S. patents for devices used in the operating room. His expertise includes aneurysms, AVMs, carotid artery disease, Moyamoya disease, spinal vascular disorders, and other cerebrovascular diseases, as well as endovascular treatment of acute stroke.

Dr. George SelasDr. Selas is an award-winning neurosurgeon with advanced training in both neuro critical care and neurointerventional procedures to treat cerebro-vascular disorders, including stroke, aneurysms, and arterious malformations (AVMs). He specializes in minimally invasive procedures, including intra-cranial stents, embolization, and other neuro-interventional techniques.

For information about these doctors, please visit brooklyndoctors.nyp.org, or call 718-780-5176 to make an appointment.

Match Day 2019New Residents in Neurological SurgeryThe results of the 2019 National Residency Match were announced on March 15, and we were delighted to learn that Alexandra Giantini Larsen of Harvard Medical School and Andrew Garton of Columbia University Vagelos College of Physicians and Surgeons will be joining our neurosurgery residency program in June. Both of our new residents have distinguished them selves as future clinician-scientist leaders and impressed us with their skills, academic accomplishments, and maturity. We are so excited to have the opportunity to train these two outstanding young physicians.